Business Wire

UT-MYHERITAGE

13.10.2020 07:21:10 CEST | Business Wire | Pressemeddelelse

Del
MyHeritage udgiver stor samling af historiske norske kirkebogsoptegnelser

MyHeritage , den førende globale tjeneste til at opdage din fortid og tage kontrol over din fremtid, annoncerede i dag offentliggørelsen af en omfattende samling af norske kirkebogsoptegnelser. MyHeritage har digitaliseret denne samling i samarbejde med Arkivverket, det norske rigsarkiv. Denne tilføjelse fordobler antallet af norske historiske optegnelser på MyHeritage og bringer den samlede antal norske historiske optegnelser i MyHeritages database op på 12,6 milliarder.

Der er multimedier i denne pressemeddelelse. Se hele meddelelsen her: https://www.businesswire.com/news/home/20201012005885/da/

Samlingen Norge Kirkebøger (1815-1938) består af 42,2 millioner fødsels-, dåbs-, vielses-, døds- og begravelsesoptegnelser, som er dokumenteret af Norges evangelisk-lutherske kirke, som udførte arbejdet med at dokumentere vitale optegnelser på regeringens vegne. Samlingen indeholder et indeks over transskriberede optegnelser og digitale billeder af de originale kirkedokumenter. Billederne har været tilgængelige gennem Norges rigsarkiv i adskillige år, men har ikke været søgbare efter navn. Dette er første gang, at kirkebøger fra Norge er blevet indekseret og gjort tilgængelige online.

Optegnelserne i denne samling dateres tilbage til 1815 og dækker en vigtig periode i Norges historie, der begynder kun et år efter dets løsrivelse fra Danmark. Denne vigtige samling hjælper med at dække de store huller i norske folketællinger fra 1801 til 1865. Fem folketællinger blev indsamlet i Norge i disse år, men de registrerede ikke navne på enkeltpersoner, hvilket gjorde kirkebøgerne til den hovedsagelige kilde til slægtsdata i den periode. På grund af norsk privatlivslov strækker fødsels- og dåbsoptegnelserne, der er inkluderet i denne samling, til og med 1919, vielsesoptegnelserne strækker sig til og med 1937, og døds- og begravelsesoptegnelserne strækker sig til og med 1938.

Med udgivelsen af denne samling har MyHeritage nu 80 millioner historiske optegnelser fra Norge. Som markedsleder inden for skandinavisk slægtsforskning, tilbyder MyHeritage også 157 millioner historiske optegnelser fra Sverige og 107 millioner optegnelser fra Danmark. MyHeritage er det eneste store slægtsforskningsfirma, der leverer sine tjenester og fuld kundesupport på alle tre skandinaviske sprog såvel som på finsk, og tilbyder den bedste mulighed for nye slægtshistoriske opdagelser for alle med skandinavisk oprindelse. MyHeritages popularitet i Norge er så høj, at en ud af fem nordmænd er en registreret bruger af MyHeritage.

”Norske kirkebogsoptegnelser er en vigtig ressource til at udforske norsk arv og forbedrer de norske historiske optegnelser, der er tilgængelige på MyHeritage, betydeligt,” sagde Russ Wilding, Chief Content Officer for MyHeritage. "Ud over det norske folk, vil millioner af mennesker med norsk herkomst, som bor udenfor Norge, få glæde af denne samling og få nye gennembrud i deres slægtshistoriske forskning."

Norges kirkebøger er tilgængelig på MyHeritages søgemaskine til historiske optegnelser. Det er gratis at søge i samlingen. Der kræves et abonnement for at se de komplette optegnelser og for at få adgang til Record Matches.

Søg i den nye Norge Kirkebøger .

Om MyHeritage

MyHeritage er den førende globale platform til at opdage og udforske slægtshistorie. Med milliarder af historiske optegnelser og slægttræsprofiler og med sofistikerede matching-teknologier på tværs af alle dens aktiver, giver MyHeritage brugere mulighed for at opdage deres fortid og tage kontrol over deres fremtid. Siden 2020 er MyHeritage stedet for verdens bedste teknologier til forbedring og farvelægning af historiske fotos. MyHeritage er den mest populære tjeneste for slægtshistorie i Europa. www.myheritage.dk

Information om Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Følg pressemeddelelser fra Business Wire

Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.

Flere pressemeddelelser fra Business Wire

New Auction Record Set as Falcon Sells for AED 1.5 Million at ADIHEX 202629.8.2026 23:54:00 CEST | Press release

Qarmousha Pure Ultra White falcon sells for AED 1.5 million at the Abu Dhabi International Hunting and Equestrian Exhibition 2026 (ADIHEX) falcon auction Under the patronage of His Highness Sheikh Hamdan bin Zayed Al Nahyan, Ruler’s Representative in Al Dhafra Region and Chairman of the Emirates Falconers’ Club, the fifth auction held as part of the 23rd edition of the Abu Dhabi International Hunting and Equestrian Exhibition (ADIHEX) 2026 attracted remarkable turnout, culminating in the sale of a Qarmousha Pure Ultra White falcon for AED 1.5 million (USD 408,000). The sale marks the highest price achieved at any auction during this year’s edition of the exhibition. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260829032621/en/ Qarmousha Pure Ultra White (Photo: AETOSWire) This forms part of the largest auction programme in the exhibition’s history, held under the theme “A Legacy of Pride,” organised by ADNEC Group, a Modon

Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera29.8.2026 00:40:00 CEST | Press release

MIMRYLO, a First-in-Class Medicine with a Unique Mechanism of Action, is Approved for the Treatment of Erythrocytosis in Adults with Polycythemia Vera (PV)MIMRYLO Has Been Shown to Maintain Hematocrit Control, the Primary Treatment Goal in PV, as Well as Reduce Phlebotomy Burden and Improve FatigueApproval Supported by Phase 3 VERIFY Results Showing 76.9% of Patients Achieved Clinical Response During Weeks 20-32 Takeda (TSE:4502/NYSE:TAK)announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for MIMRYLO™ (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260824773270/en/ MIMRYLO Logo MIMRYLO is a first-in-class hepcidin mimetic designed to regulate iron distribution in the body and red blood cell overproduction to control hematocrit levels, which is the ratio of red blood cells to the tot

Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 16:00:00 CEST | Press release

Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me

BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 15:34:00 CEST | Press release

Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro

Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 11:00:00 CEST | Press release

Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026 The approval is based on data from the Phase 3 RISE-PD trial where Hopledo® demonstrated a significant increase in Good ON time compared with immediate-release LD/CD with fewer daily doses and a comparable safety profile Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely

I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.

Besøg vores nyhedsrum
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye